Pyridoxine dependency and central nervous system excitability.
D000161:Acoustic Stimulation; D000375:Aging; D000613:Aminobutyrates / Q000378:metabolism; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D004347:Drug Interactions; D004558:Electric Stimulation; D005838:Genotype; D051379:Mice; D008815:Mice, Inbred Strains; D009638:Norepinephrine / Q000032:analysis; D010433:Pentylenetetrazole; D010649:Phenylalanine / Q000097:blood; D010651:Phenylalanine Hydroxylase / Q000378:metabolism; D010830:Physostigmine; D011736:Pyridoxine / Q000378:metabolism*; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced / Q000201:enzymology / Q000209:etiology / Q000235:genetics / Q000378:metabolism*; D012701:Serotonin / Q000032:analysis; D013747:Tetrabenazine / Q000494:pharmacology; D013882:Thiosemicarbazones
D000613:Aminobutyrates; D013882:Thiosemicarbazones; D012701:Serotonin; D010649:Phenylalanine; D012110:Reserpine; D010830:Physostigmine; D010651:Phenylalanine Hydroxylase; D011736:Pyridoxine; D010433:Pentylenetetrazole; D009638:Norepinephrine; D013747:Tetrabenazine